Literature DB >> 22422321

Pharmacokinetic/pharmacodynamic modeling of methylprednisolone effects on iNOS mRNA expression and nitric oxide during LPS-induced inflammation in rats.

Siddharth Sukumaran1, Eve-Irene Lepist, Debra C DuBois, Richard R Almon, William J Jusko.   

Abstract

PURPOSE: Increased expression of inducible nitric oxide synthase (iNOS) resulting in nitric oxide elevation represents an important component of inflammatory responses. We assess the effects of methylprednisolone (MPL) on these processes during endotoxin-induced acute inflammation and provide a mechanism-based model to quantitatively describe them.
METHODS: Male Lewis rats were dosed with lipopolysaccharide (50 μg/kg LPS) alone or with methylprednisolone (10 and 50 mg/kg) and sacrificed at different time points. Plasma MPL, lung iNOS mRNA expression, plasma nitric oxide (NO) and other physiological factors were measured. Sodium nitrate (750 μmole/kg) was given to a separate cohort of rats to assess NO disposition kinetics. PK-PD modeling was performed with ADAPT 5.
RESULTS: Disposition kinetics of plasma MPL and NO showed bi-exponential decline and were described by two-compartment models. LPS increased expression of iNOS mRNA in lung and increased plasma NO, while MPL dosing palliated this increase in a dose-dependent manner. These effects were well captured using tandem indirect response and precursor-pool models.
CONCLUSION: The model provides a quantitative assessment of the suppression of NO production by MPL and shows that the major effects are at the transcriptional level by reducing expression of iNOS mRNA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422321      PMCID: PMC3400266          DOI: 10.1007/s11095-012-0733-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 2.  Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic?

Authors:  S P Sanders
Journal:  Am J Respir Cell Mol Biol       Date:  1999-08       Impact factor: 6.914

Review 3.  Inducible nitric oxide synthase and inflammatory diseases.

Authors:  R Zamora; Y Vodovotz; T R Billiar
Journal:  Mol Med       Date:  2000-05       Impact factor: 6.354

Review 4.  Nitric oxide in inflammatory bowel disease.

Authors:  Raymond K Cross; Keith T Wilson
Journal:  Inflamm Bowel Dis       Date:  2003-05       Impact factor: 5.325

5.  Molar quantification of specific messenger ribonucleic acid expression in northern hybridization using cRNA standards.

Authors:  D C DuBois; R R Almon; W J Jusko
Journal:  Anal Biochem       Date:  1993-04       Impact factor: 3.365

Review 6.  Molecular biology of endotoxin antagonism.

Authors:  Victor Lazaron; David L Dunn
Journal:  World J Surg       Date:  2002-04-15       Impact factor: 3.352

7.  Liposomal methylprednisolone in rats: dose-proportionality and chronic-dose pharmacokinetics/pharmacodynamics.

Authors:  E V Mishina; W J Jusko
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

8.  Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells.

Authors:  Jun Shinoda; Katherine E McLaughlin; Helen S Bell; Gopal R Swaroop; Shin-Ichi Yamaguchi; Megan C Holmes; Ian R Whittle
Journal:  Glia       Date:  2003-04-01       Impact factor: 7.452

9.  Effects of acute and chronic inflammation on the pharmacokinetics of prednisolone in rats.

Authors:  V Garg; Y Y Hon; W J Jusko
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

10.  Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats.

Authors:  L Givalois; J Dornand; M Mekaouche; M D Solier; A F Bristow; G Ixart; P Siaud; I Assenmacher; G Barbanel
Journal:  Am J Physiol       Date:  1994-07
View more
  5 in total

Review 1.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

2.  Pharmacokinetics and Pharmacodynamics of the Triterpenoid Ursolic Acid in Regulating the Antioxidant, Anti-inflammatory, and Epigenetic Gene Responses in Rat Leukocytes.

Authors:  Chengyue Zhang; Chao Wang; Wenji Li; Renyi Wu; Yue Guo; David Cheng; Yuqing Yang; Ioannis P Androulakis; Ah-Ng Kong
Journal:  Mol Pharm       Date:  2017-10-25       Impact factor: 4.939

3.  Pharmacokinetics and Pharmacodynamics of Curcumin in regulating anti-inflammatory and epigenetic gene expression.

Authors:  Sarandeep S S Boyanapalli; Ying Huang; Zhengyuan Su; David Cheng; Chengyue Zhang; Yue Guo; Rohit Rao; Ioannis P Androulakis; Ah-Ng Kong
Journal:  Biopharm Drug Dispos       Date:  2018-06       Impact factor: 1.627

4.  Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats.

Authors:  Yingfan Hu; Li Wang; Li Xiang; Jiasi Wu; Wen'ge Huang; Chensi Xu; Xianli Meng; Ping Wang
Journal:  Sci Rep       Date:  2019-02-05       Impact factor: 4.379

5.  Semi-Mechanism-Based Pharmacodynamic Model for the Anti-Inflammatory Effect of Baicalein in LPS-Stimulated RAW264.7 Macrophages.

Authors:  Li Xiang; Ying-Fan Hu; Jia-Si Wu; Li Wang; Wen-Ge Huang; Chen-Si Xu; Xian-Li Meng; Ping Wang
Journal:  Front Pharmacol       Date:  2018-07-18       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.